Reported Reactions

Devices › System, x-ray, tomography, computed

Device brand name · Computed tomography x-ray

Brilliance 64: medical device reports filed with FDA

357 reports name it, 2009–2018. Manufacturer given most often on reports: Philips Medical Systems Cleveland. Product code JAK.

357
device reports naming the brand
0% of all MAUDE reports · about 21 a year
0
reports, 12 months to August 2026
0 in the 12 months before
58%
classified as malfunction
54.1% across the product code
0.6%
classified as death, as reported
2 reports · not verified by FDA

FDA's MAUDE database holds 357 reports that name the brand "Brilliance 64" (computed tomography x-ray), received between July 2009 and May 2018; the manufacturer given most often on reports is Philips Medical Systems Cleveland. Spellings of one product vary from report to report.

0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (58%), injury (2.8%) and other (1.1%); across all system, x-ray, tomography, computed reports (product code JAK) death is recorded in 4.2% and malfunction in 54.1%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are signal artifact/noise (23.8%), device operates differently than expected (23.2%) and degraded (12.6%). The patient problems coded most often are no patient involvement, misdiagnosis and electric shock. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

No report naming Brilliance 64 was received in the five years to August 2026; the latest was received in May 2018.

By year received

043862009: 320092010: 1120102011: 1320112012: 3020122013: 8620132014: 5320142015: 8220152016: 820162017: 1520172018: 562018

Event type and report source

Event type, as classified on the report

Death0.6%2
Injury2.8%10
Malfunction58%207
Other1.1%4
Not given37.5%134

Who filed the report

Manufacturer report99.4%355
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0.6%2

Grey bar: all 5,268 reports carrying product code JAK. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Signal artifact/noise8523.8%9.1%
Device operates differently than expectedthe device behaved unexpectedly8323.2%8.9%
Degraded4512.6%5.6%
Mechanical problema mechanical problem4211.8%3.5%
Sticking298.1%1.8%
Unintended movement298.1%2.5%
Unintended system motionthe device moved when it should not have205.6%2.9%
Detachment of device or device componentpart of the device came off133.6%1.2%
Loose or intermittent connection123.4%0.8%
Detachment of device component102.8%1.5%
Device displays incorrect message92.5%6.3%
Smoking92.5%0.9%
Calibration problem72%0.5%
Breakthe device broke61.7%2.2%
Component falling61.7%0.9%
Device slipped61.7%0.4%
Application network problem51.4%0.9%
Communication or transmission problemthe device could not communicate or transmit51.4%1.3%
Computer software problema software problem51.4%2.1%
Image display error/artifact51.4%1.9%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
No patient involvement205.6%
Misdiagnosis41.1%
Electric shockan electric shock20.6%
Head injurya head injury20.6%
Injurya physical injury20.6%
Swellingswelling20.6%
Blurred vision10.3%
Bruise/contusion10.3%
Cardiac arrestthe heart stopped10.3%
Deaththe patient died; cause not stated by this term10.3%
Discomfortdiscomfort10.3%
Extravasation10.3%
Hemorrhage/blood loss/bleeding10.3%
Infiltration into tissue10.3%
Laceration(s)10.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBrilliance 64Product code JAKAll MAUDE reports
Reports3575,26826,136,888
Share of that pool—6.8%0%
Classified as death, per 1,000 reports6429
Classified as injury2.8%28.9%36.2%
Classified as malfunction58%54.1%62.3%
Filed by the manufacturer99.4%89.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code JAK

BrandReportsLatest 12 monthsClassified as death
Superdimension Inreach System398026.6%
Illumisite380700.5%
Brilliance 16 Air24900.4%
Ict22200.5%
Superdimension Inreach Bronchus System213014.1%
Superdimension22757%
Edge8591710.1%
Toshiba15801.9%
Acist3481410.6%
Philips19006.3%
Artis zee biplane18271.1%
Artis Zee Ceiling20940.5%
Bd Vacutainer Push Button Blood Collection Set With Pre-Attached Holder20600%
BD Vacutainer Safety-Lok Blood Collection Set8191440%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Brilliance 64 reports

How many FDA reports name Brilliance 64?

357 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.

What kinds of events are reported?

malfunction (58%), injury (2.8%) and other (1.1%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

signal artifact/noise (23.8%), device operates differently than expected (23.2%), degraded (12.6%), mechanical problem (11.8%) and sticking (8.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (99.4%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Brilliance 64 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.